Related Experiment Videos
The costs of rheumatoid arthritis. A patient-oriented study of chronic disease costs
Insights
Rheumatoid arthritis patients face high costs, with indirect income losses significantly exceeding direct medical expenses. Uncovered losses pose the greatest financial burden, impacting individuals and health policy.
Area of Science:
- Rheumatology
- Health Economics
- Public Health Policy
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease causing significant morbidity.
- Understanding the economic burden of RA is crucial for effective patient support and policy development.
Purpose of the Study:
- To quantify the direct medical and indirect costs associated with rheumatoid arthritis over one year.
- To assess the impact of insurance and transfer payments on mitigating these costs.
- To identify the primary economic burden for individuals with chronic RA.
Main Methods:
- Survey of 50 patients diagnosed with Stage III rheumatoid arthritis.
- Analysis of direct medical costs, indirect costs (lost income), and psychosocial losses.
- Evaluation of insurance coverage and transfer payment impact on total costs.
Main Results:
- Direct medical costs for RA patients were triple the national average, with 58% covered by insurance.
- Indirect costs (lost income) were at least three times higher than direct medical costs.
- Transfer payments covered only 42% of indirect costs, with uncovered income losses representing the greatest economic burden.
- 58% of patients experienced major psychosocial loss.
Conclusions:
- The economic impact of rheumatoid arthritis is substantial, driven primarily by indirect costs and income loss.
- Current insurance and transfer payment systems inadequately cover the full economic burden of RA.
- Findings highlight the need for revised health policies and medical practices to address the comprehensive costs of chronic disease management.
Abstract:
To detail the cost for one year of a chronic disease, 50 patients with Stage III rheumatoid arthritis were surveyed. Direct medical costs for this group were three times the national average, and 58% of these costs were covered by insurance. Indirect costs due to lost income were at least three times the direct medical costs, and transfer payments covered only 42% of these costs. Fifty-eight percent of the study group also sustained a major psychosocial loss. Uncovered income losses were the greatest economic burden for individuals with chronic rheumatoid arthritis. This striking ratio of indirect to direct medical costs has important implications for medical practice and health policy.